Skip to main content
OpenTrials

Clinical trial condition

Pituitary ACTH Hypersecretion

Explore clinical trials studying Pituitary ACTH Hypersecretion. Study availability and eligibility vary by location and protocol.

46 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Pituitary ACTH Hypersecretion trial results

Completed

Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly

NCT02060383

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +14 more
Locations
  • Diabetes and Endocrine Associates La Mesa Location Multiple Locations, California, United States
  • LA Biomedical Research at Harbor UCLA Medical Center SC - SOM230B2219 Torrance, California, United States
  • Coastal Metabolic Research Centre SC Ventura, California, United States
  • East Coast Institute for Research East Coast Inst. for Res(ECIR) Jacksonville, Florida, United States
View all 43 locations
View Trial Details
Completed

An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.

NCT01582061

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +15 more
Locations
  • Advanced Research, LLC Peoria, Arizona, United States
  • St Josephs Hospital & Medical Center St Joes Phoenix, Arizona, United States
  • University of California at Los Angeles UCLA Tiverton Los Angeles, California, United States
  • LA Biomedical Research at Harbor UCLA Medical Center Torrance, California, United States
View all 65 locations
View Trial Details
Completed

Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease

NCT01374906

Conditions
Brain Diseases, Central Nervous System Diseases, Cushing's Disease, +6 more
Locations
  • ClinTriCo Phoenix, Arizona, United States
  • University of California at Los Angeles UCLA Tiverton Los Angeles, California, United States
  • Harbor-UCLA Medical Center LA Biomed Torrance, California, United States
  • Emory University School of Medicine/Winship Cancer Institute G2304 - C2301 Atlanta, Georgia, United States
View all 82 locations
View Trial Details
Completed

Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease

NCT00434148

Conditions
Brain Diseases, Central Nervous System Diseases, Cushing's Disease, +6 more
Locations
  • Stanford University Medical Center Stanford Cancer Center (3) Stanford, California, United States
  • University Chicago Hospital Dept. of Univ of Chicago Chicago, Illinois, United States
  • Dana Farber Cancer Institute The Melanoma Program Boston, Massachusetts, United States
  • Columbia University Medical Center- New York Presbyterian Columbia University DeptofMed New York, United States
View all 68 locations
View Trial Details
Completed

An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome

NCT00936741

Conditions
ACTH Syndrome, Ectopic, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +27 more
Locations
  • University of Alabama at Birmingham School of Medicine Birmingham, Alabama, United States
  • AMCR Institute Inc. Escondido, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • The Center for Diabetes and Endocrine Care Hollywood, Florida, United States
View all 15 locations
View Trial Details

Related conditions